Hand Sanitizer (Pharmacies) - Brunei Darussalam

  • Brunei Darussalam
  • Revenue in the Hand Sanitizer market is projected to reach US$429.90k in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 3.25%, resulting in a market volume of US$504.40k by 2029.
  • In global comparison, most revenue will be generated in China (US$385.20m in 2024).
  • In relation to total population figures, per person revenues of US$0.94 are generated in 2024.

Key regions: Japan, United States, Europe, United Kingdom, Canada

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Hand Sanitizer (Pharmacies) market in Brunei Darussalam has experienced significant growth in recent years.

Customer preferences:
Customers in Brunei Darussalam have shown a growing preference for hand sanitizers purchased from pharmacies. This preference can be attributed to several factors. Firstly, customers trust the quality and reliability of hand sanitizers sold in pharmacies, as they are regulated and approved by the relevant authorities. Secondly, pharmacies often offer a wider range of hand sanitizer products, catering to different customer needs and preferences. Lastly, customers appreciate the convenience of purchasing hand sanitizers alongside other healthcare products in pharmacies.

Trends in the market:
One of the key trends in the Hand Sanitizer (Pharmacies) market in Brunei Darussalam is the increasing demand for alcohol-based hand sanitizers. This trend is driven by the effectiveness of alcohol-based sanitizers in killing germs and viruses, including the coronavirus. Customers are becoming more aware of the importance of hand hygiene and are seeking products that provide maximum protection. Another trend in the market is the growing popularity of natural and organic hand sanitizers. Customers are becoming more conscious of the ingredients used in personal care products and are opting for products that are free from harsh chemicals. This trend is also influenced by the global shift towards sustainability and eco-friendly products.

Local special circumstances:
Brunei Darussalam has a small population, which has contributed to the growth of the Hand Sanitizer (Pharmacies) market. With a smaller customer base, pharmacies are able to cater to the specific needs and preferences of the local population. This has led to the availability of a wide range of hand sanitizer products in pharmacies, ensuring that customers can find the product that best suits their requirements.

Underlying macroeconomic factors:
The growth of the Hand Sanitizer (Pharmacies) market in Brunei Darussalam can be attributed to several macroeconomic factors. Firstly, the country has a high standard of healthcare, with a well-developed healthcare system and a strong emphasis on hygiene. This has created a favorable environment for the growth of the hand sanitizer market. Secondly, the COVID-19 pandemic has significantly increased the demand for hand sanitizers worldwide, and Brunei Darussalam is no exception. The government and health authorities have placed a strong emphasis on hand hygiene as a preventive measure against the spread of the virus, leading to increased awareness and demand for hand sanitizers. Lastly, Brunei Darussalam has a stable and growing economy, which has contributed to the affordability and accessibility of hand sanitizers. Customers are willing to invest in personal hygiene products, including hand sanitizers, to protect their health and well-being. In conclusion, the Hand Sanitizer (Pharmacies) market in Brunei Darussalam has experienced growth due to customer preferences for pharmacy-sold products, the increasing demand for alcohol-based and natural hand sanitizers, local special circumstances, and underlying macroeconomic factors. As the importance of hand hygiene continues to be emphasized, the market is expected to further expand in the coming years.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)